Simvastatin, Vitamin D3 Combo Helps Prevent Migraines

This article originally appeared here.
Share this content:
Simvastatin, Vitamin D3 Combo Helps Prevent Migraines
Simvastatin, Vitamin D3 Combo Helps Prevent Migraines

MONDAY, Oct. 5, 2015 (HealthDay News) -- In adults with episodic migraine, the combination of simvastatin and vitamin D3 seems effective for prevention of headache, according to a study published online Sept. 29 in the Annals of Neurology.

Catherine Buettner, M.D., M.P.H., from the Beth Israel Deaconess Medical Center in Boston, and colleagues examined the efficacy and tolerability of simvastatin plus vitamin D for migraine prevention. Fifty-seven adults with episodic migraine were randomized to simvastatin 20 mg tablets twice daily plus vitamin D3 1,000 IU capsules twice daily or matching placebo tablets and capsules during a 24-week intervention period.

The researchers found that, compared with placebo, participants using simvastatin plus vitamin D3 demonstrated a greater decrease in number of migraine days from the baseline period to intervention weeks one to 12 (−8.0 versus +1.0 days; P < 0.001) and to intervention weeks 13 to 24 (−9.0 versus +3.0 days; P < 0.001). In the active treatment group, 25 and 29 percent of patients experienced a 50 percent reduction in the number of migraine days at 12 and 24 weeks post randomization, respectively. Only 3 percent of patients experienced such reduction in the placebo group (P = 0.003). The treatment and placebo groups reported similar adverse events.

"Given statins ability to repair endothelial dysfunction, this economical approach may also reduce the increased risk for vascular diseases among migraineurs," the authors write.

Two authors disclosed financial ties to the pharmaceutical industry; two authors and their institution have applied for a patent for the combination of statin and vitamin D as prophylactic treatment for migraine.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »